Receptor guanylyl cyclase (RGC) family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Authors

  • Annie Beuve Rutgers University
  • Peter Brouckaert Vlaams Instituut voor Biotechnologie
  • John C. Burnett, Jr. Mayo Clinic
  • Andreas Friebe Universität Würzburg
  • John Garthwaite University College London
  • Adrian J. Hobbs Queen Mary University of London
  • Doris Koesling Ruhr-Universität Bochum
  • Michaela Kuhn Physiologisches Institut der Universität Würzburg
  • Lincoln R. Potter University of Minnesota
  • Michael Russwurm Ruhr University Bochum
  • Harald H.H.W. Schmidt Maastricht University
  • Johannes-Peter Stasch Bayer AG
  • Scott A. Waldman Thomas Jefferson University

DOI:

https://doi.org/10.2218/gtopdb/F1022/2019.4

Abstract

The mammalian genome encodes transmembrane and soluble receptor guanylyl cyclases, both of which have enzyme activities which convert guanosine-5'-triphosphate to the intracellular second messenger cyclic guanosine-3',5'-monophosphate (cyclic GMP).

Downloads

Published

16-Sep-2019

Issue

Vol. 2019 No. 4 (2019)

Section

Summaries

How to Cite

“Receptor guanylyl cyclase (RGC) family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database” (2019) IUPHAR/BPS Guide to Pharmacology CITE, 2019(4). doi:10.2218/gtopdb/F1022/2019.4.